Stay updated on Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial
Sign up to get notified when there's something new on the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page.

Latest updates to the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision tag updated to v3.5.0; the v3.4.3 tag has been removed.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a system version update with no visible impact on trial information or user-facing features.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page header revision label was updated from v3.4.1 to v3.4.2 (v3.4.1 removed).SummaryDifference0.1%

- Check75 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing the previous Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a glossary display option, the 'Last Update Submitted that Met QC Criteria' entry, the 'No FEAR Act Data' section, and a 'Revision: v3.4.0' note. Removed the older 'Last Update Submitted that met QC Criteria' entry, the 'No FEAR Act data' label, and the 'Revision: v3.3.4' note.SummaryDifference0.2%

Stay in the know with updates to Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page.